CN Patent

CN103180324A — 腔肠素衍生物及其使用方法

Assigned to Promega Corp · Expires 2013-06-26 · 13y expired

What this patent protects

本发明提供作为非发光酶的底物和发光酶的前底物的腔肠素衍生物。本发明还提供一种使用所述衍生物的方法。

USPTO Abstract

本发明提供作为非发光酶的底物和发光酶的前底物的腔肠素衍生物。本发明还提供一种使用所述衍生物的方法。

Drugs covered by this patent

trilaciclib-dihydrochloride (TRILACICLIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN103180324A
Jurisdiction: CN
Classification: —
Expires: 2013-06-26
Drug substance claim: No
Drug product claim: No
Assignee: Promega Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.